View full meeting coverage »

Eyetube Meeting Coverage:

AAO 2019



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Clinical Use of Cenegermin-bkbj Ophthalmic Solution for NK

  Channels: Cornea | Posted 9/11/2019

Find out why Giacomina Massaro-Giordano, MD, considers cenegermin-bkbj ophthalmic solution 0.002% (Oxervate, Dompé) to be a game changer for the treatment of patients with neurotrophic keratitis (NK).

neurotrophic keratitis

13 / 35 Series: AAO 2019

More Videos in this Series

View full meeting coverage (35 videos)
These programs are not affiliated with the official program of AAO 2019.